Organogenesis Holdings ORGO Income Statement (2015-2026)

NASDAQ ORGO
$1.59 -0.01 (-0.94%)
As of: Sep 9, 2026 · 11:21 AM EDT
Reported Financials

Organogenesis Holdings Quarterly Income Statement

Periods 42 quarters
Latest Jun 2026

Organogenesis Holdings reported revenue of $43.76M and net income of -$99.34M for the quarter ended Jun 2026, down 56.7% year over year. This income statement covers 42 quarters of results from Dec 2015 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Income Statement Dec2015 Mar2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Revenue & cost
Revenue
113.75M127.86M97.12M121.40M116.86M115.52M107.64M117.32M108.53M99.65M109.98M130.23M115.18M126.66M86.69M101.00M150.86M225.61M37.23M43.76M
Cost of RevenueCost of Rev
26.17M32.60M25.08M26.65M26.18M27.11M26.61M26.32M25.79M27.77M28.70M29.20M26.80M31.05M23.72M27.63M36.25M49.92M25.77M23.67M
Gross Profit
87.59M95.26M72.04M94.75M90.68M88.41M81.03M91.00M82.74M71.88M81.28M101.04M88.38M95.61M62.97M73.38M114.61M175.69M11.46M20.08M
Operating items
Research & DevelopmentR&D
8.95M8.26M8.59M10.21M9.57M11.39M11.20M10.94M10.47M11.77M12.81M15.59M10.34M11.53M10.64M10.39M13.22M10.29M15.16M18.30M
Selling, General & AdministrativeSG&A
62.37M67.25M63.58M72.61M79.33M68.29M73.83M70.32M64.22M61.38M72.32M76.54M71.80M1.19M72.51M73.81M79.74M100.17M65.19M53.97M
Other Operating ExpensesOther Opex
106.48M52.00M26.80M103.72M30.29M29.38M37.17M51.86M25.77M22.48M
Operating ExpensesOpex
71.32M75.51M72.17M82.81M88.90M79.69M85.04M81.25M74.69M179.63M85.13M144.13M108.94M116.44M113.44M113.58M130.14M162.32M106.12M94.75M
Operating IncomeOp. Inc
16.26M19.75M-0.13M11.94M1.78M8.72M-4.00M9.74M8.05M-1.27M-3.85M-13.89M6.24M10.22M-26.75M-12.58M20.73M63.29M-68.89M-50.99M
EBIT
16.26M19.75M-0.13M11.94M1.78M8.72M-4.00M9.74M8.05M-1.27M-3.85M-13.89M6.24M10.22M-26.75M-12.58M20.73M63.29M-68.89M-50.99M
Non-operating items
Non Operating Interest Expenses
1.48M0.85M0.74M0.73M0.57M-0.03M0.65M0.59M0.44M0.50M0.51M0.62M0.47M-0.06M-0.96M-0.67M-0.41M-0.24M-0.38M-0.14M
Interest & Investment IncomeInt & Inv Inc
Other Non Operating IncomeOther Non Op Inc.
-1.88M-0.00M-0.02M0.01M0.01M0.02M0.03M0.03M-0.03M0.02M-0.03M0.05M-0.03M0.00M0.07M0.02M7.21M0.04M-0.03M
Non Operating IncomeNon Op. Inc.
-3.38M-0.86M-0.74M-0.75M-0.57M0.04M-0.63M-0.57M-0.41M-0.53M-0.49M-0.65M-0.42M0.03M0.96M0.74M0.43M0.14M0.42M0.11M
Net income details
EBT
12.88M18.89M-0.87M11.18M1.21M8.75M-4.63M9.18M7.64M-1.80M-4.34M-14.54M5.82M10.25M-25.78M-11.83M21.16M63.43M-68.47M-50.88M
Tax ProvisionsTaxes
0.30M-32.11M0.04M2.44M1.00M1.27M-1.66M3.86M4.47M-1.23M-2.24M2.50M-6.51M13.30M-6.94M-2.44M-0.41M19.73M-15.32M45.39M
Profit After TaxPAT
12.58M50.99M-0.91M8.74M0.21M7.49M-2.97M5.32M3.17M-0.57M-2.10M-17.04M12.33M5.88M-21.59M-12.20M21.57M52.13M-56.16M-99.34M
Income from Non-Controlling InterestsInc. Minority
Income from Continuing OperationsIncome (Continuing)
12.58M50.99M-0.91M8.74M0.21M7.49M-2.97M5.32M3.17M-0.57M-2.10M-17.04M12.33M-3.05M-18.84M-9.39M21.57M43.70M-53.16M-96.27M
Consolidated Net IncomeConsol Net Inc.
12.58M50.99M-0.91M8.74M0.21M7.49M-2.97M5.32M3.17M-0.57M-2.10M-17.04M12.33M-3.05M-18.84M-9.39M21.57M43.70M-53.16M-96.27M
Income towards Parent CompanyParent Net Inc
12.58M50.99M-0.91M8.74M0.21M7.49M-2.97M5.32M3.17M-0.57M-2.10M-17.04M12.33M-3.05M-18.84M-9.39M21.57M43.70M-53.16M-96.27M
Preferred Dividend PaymentsPref Dividends
0.41M2.63M0.13M0.14M0.15M2.84M0.17M
Net Income towards Common StockholdersNet Income
12.58M50.99M-0.91M8.74M0.21M7.49M-2.97M5.32M3.17M-0.57M-2.10M-17.04M12.33M5.88M-21.59M-12.20M14.53M40.76M-56.16M-99.34M
Additional items
EPS (Basic)
0.100.40-0.010.070.000.06-0.020.040.020.00-0.02-0.130.090.04-0.17-0.100.110.32-0.44-0.77
EPS (Diluted)
0.090.38-0.010.070.000.06-0.020.040.020.00-0.02-0.130.090.04-0.17-0.100.110.31-0.44-0.77
Shares Outstanding
128.55M128.33M128.79M129.64M130.90M130.07M131.08M131.29M131.31M131.23M131.86M132.57M132.58M131.67M126.30M126.85M126.88M126.74M127.80M128.67M
Shares Outstanding (Diluted)Shares Outstanding (Dil.)
133.85M133.66M132.81M132.60M132.23M132.38M131.08M133.07M133.42M132.75M131.86M132.57M133.93M131.67M126.30M126.85M130.85M130.25M127.80M128.67M
Shares Outstanding (Entity)Shares Outstanding (Entity.)
128.64M128.68M128.89M130.89M130.92M130.92M131.23M131.31M131.31M131.32M132.54M132.57M132.58M125.73M126.85M126.85M126.91M126.95M128.67M128.67M
EBITDA
16.26M19.75M-0.13M11.94M1.78M8.72M-4.00M9.74M8.05M-1.27M-3.85M-13.89M6.24M10.22M-26.75M-12.58M20.73M63.29M-68.89M-50.99M
Interest ExpensesInt Expense
1.48M0.85M0.74M0.73M0.57M-0.03M0.65M0.59M0.44M0.50M0.51M0.62M0.47M-0.06M-0.96M-0.67M-0.41M-0.24M-0.38M-0.14M
Tax Rate
2.35%-169.97%-5.18%21.82%82.26%14.48%35.83%42.09%58.53%68.37%51.65%-17.21%-111.76%129.71%26.92%20.64%-1.92%31.10%22.37%-89.20%